GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) was the target of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 132,900 shares, a decline of 16.8% from the October 15th total of 159,800 shares. Based on an average daily volume of 147,900 shares, […]
GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
GT Biopharma, Inc (GTBP) Tops Q3 EPS by 3c streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) saw a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 102,200 shares, a growth of 122.2% from the September 15th total of 46,000 shares. Based on an average daily trading volume, of 265,000 shares, the short-interest […]